SyntekaBio Inc (226330) — Cash Flow Reinvestment Rate
Latest as of December 2019:
0.06x
SyntekaBio Inc (226330) has a Cash Flow Reinvestment Rate of 0.06x as of December 2019, reinvesting ₩924.66 Million (capex ₩924.66 Million ) from operating cash flow of ₩15.10 Billion. Check 226330 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.06x
(Capex + Investments) / Operating CF
Total Reinvested
₩924.66 Million
Capex + Investments
Operating Cash Flow
₩15.10 Billion
KRW
Capital Expenditures
₩924.66 Million
KRW
Annual Cash Flow Reinvestment Rate for SyntekaBio Inc (None–None)
Year-by-year capital reinvestment analysis for SyntekaBio Inc. For live market cap and broader valuation context, see SyntekaBio Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow